Dongzhou Liu

Company: Huadong Medicine

Job title: Chief Scientific Officer

Seminars:

12:30pm Discovering & Translating Novel Target ADCs 12:30 pm

Outlining approaches to identifying new targets to differentiate your ADC pipeline and drive your ADC to first-in-class Discussing ROR-1 as a target, and the current unmet medical need for ROR-1 associated cancers Defining future considerations on X-X conjugation drugsRead more

day: Day Two Preclinical & Clinical Development Track